Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,760
  • Shares Outstanding, K 25,754
  • Annual Sales, $ 1,750 K
  • Annual Income, $ -20,760 K
  • 60-Month Beta 1.21
  • Price/Sales 23.33
  • Price/Cash Flow N/A
  • Price/Book 0.95

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.50 +0.33%
on 11/05/19
1.69 -10.85%
on 10/24/19
-0.13 (-7.95%)
since 10/10/19
3-Month
1.50 +0.33%
on 11/05/19
1.75 -14.00%
on 09/09/19
-0.15 (-9.06%)
since 08/12/19
52-Week
1.34 +12.31%
on 08/06/19
2.71 -44.46%
on 11/14/18
-1.23 (-44.87%)
since 11/12/18

Most Recent Stories

More News
Biomica Reports Positive Preliminary Results in Animal Studies in Its Immuno-oncology Program

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today positive preliminary results...

EVGN : 1.50 (-4.92%)
Canonic Announces Initiation of Cultivation and Breeding of Cannabis Varieties with Unique Genomic Profiles for the Development of Medical Cannabis Products

Canonic, a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) focused on the development of medical cannabis products, announces today the initiation of its cultivation and breeding program...

EVGN : 1.50 (-4.92%)
Evogene Financial Results for the Third Quarter of 2019 Earnings Announcement Schedule

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it will release its financial results for the third quarter...

EVGN : 1.50 (-4.92%)
Biomica to Collaborate With Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic Resistant Bacteria

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today a collaboration with the...

EVGN : 1.50 (-4.92%)
Biomica Announces Advancement to Pre-Clinical Studies in its Inflammatory Bowel Disease Program

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) and (TASE: EVGN), announces today the initiation of pre-clinical...

EVGN : 1.50 (-4.92%)
Lavie Bio, Evogene's Ag-Biologicals Subsidiary, Announces the Nomination of Industry Experts to its Board of Directors

Lavie Bio, a subsidiary of Evogene (NASDAQ: EVGN) (TASE: EVGN), focusing on improving food quality, agricultural sustainability and productivity through the development of novel microbiome based agriculture...

EVGN : 1.50 (-4.92%)
Canonic to Present at CannX, 4th International Medical Cannabis Conference in Tel Aviv

Canonic, a fully owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), developing medical cannabis products, announces today that Dr. Arnon Heyman, Canonic's CEO, will present at CannX, 4th International...

EVGN : 1.50 (-4.92%)
Corteva Agriscience to Invest in Evogene's Agriculture Biologicals Subsidiary, Lavie Bio

Corteva, Inc. (NYSE: CTVA), a leading pure-play agriculture company, and Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced...

EVGN : 1.50 (-4.92%)
CTVA : 26.72 (-0.07%)
Evogene Reports Second Quarter of 2019 Financial Results

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today its financial results for the second quarter ending June 30,...

EVGN : 1.50 (-4.92%)
Evogene Amends its Collaboration Agreement With Bayer to Include Genome Editing Targets

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announces today that after achieving positive results, its corn disease resistance...

EVGN : 1.50 (-4.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade EVGN with:

Business Summary

Evogene Ltd. is a plant genomics company. The Company uses plant genomics and its technology platform to develop seed traits underlying crop performance and productivity. Evogene Ltd. is headquartered in Rehovot, Israel.

See More

Key Turning Points

2nd Resistance Point 1.50
1st Resistance Point 1.50
Last Price 1.50
1st Support Level 1.50
2nd Support Level 1.50

See More

52-Week High 2.71
Fibonacci 61.8% 2.19
Fibonacci 50% 2.03
Fibonacci 38.2% 1.86
Last Price 1.50
52-Week Low 1.34

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar